Johanne Pereira Ribeiro

8PUBLICATIONS
31CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedPsychopharmacologyClinical pharmacology and therapeuticsStochastic analysis and modellingClinical psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 08, 2026
Methylphenidate denied access to WHO's list of essential medicines for the third time.

Ole Jakob Storebø, Henriette Edemann-Callesen, Johanne Pereira Ribeiro

|Sep 02, 2025
Short-term versus long-term psychotherapy for borderline personality disorder: a protocol for an individual patient data pooled analysis of two randomised clinical trials.

Sophie Juul, Shelley McMain, Markus Harboe Olsen

|Oct 20, 2024
Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses.

Johanne Pereira Ribeiro, Sophie Juul, Mickey T Kongerslev

|Sep 09, 2024
Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses - the METSA systematic review.

Christian Gunge Riberholt, Markus Harboe Olsen, Joachim Birch Milan

|Nov 04, 2022
Perspectives on Dialectical Behavior Therapy and Mentalization-Based Therapy for Borderline Personality Disorder: Same, Different, Complementary?

Jutta M Stoffers-Winterling, Ole Jakob Storebø, Erik Simonsen

|Feb 20, 2022
Methylphenidate denied access to the WHO List of Essential Medicines for the second time.

Johanne Pereira Ribeiro, Charlotte Lunde, Christian Gluud

Pageof 2

Frequent Collaborators

6 joint publications

Ole Jakob Storebø

3 joint publications

Jutta Stoffers-Winterling

3 joint publications

Sophie Juul

2 joint publications

Henriette Edemann-Callesen